ArticleProceedings of the National Academy of Sciences of the United States of America2016

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.

Jonas Kloepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.